Kalaris Therapeutics (KLRS) EPS (2019 - 2026)
Kalaris Therapeutics (KLRS) EPS from Dec 31, 2019 to Mar 31, 2026. The TTM Kalaris Therapeutics (KLRS) EPS is -$2.15. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Kalaris Therapeutics (KLRS) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -76.75% |
| 3 Years TTM | -63.93% |
| 5 Years TTM | -42.32% |
| All Time TTM | -35.97% |
Annual EPS change of Kalaris Therapeutics (KLRS)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.47 | -75.10% |
| 2025 | -$1.90 | -79.80% |
| 2024 | -$9.39 | -75.52% |
| 2023 | -$38.37 | -7.91% |
| 2022 | -$41.66 | -33.01% |
| 2021 | -$62.19 | +140.09% |
| 2020 | -$25.90 | +128.13% |
| 2019 | -$11.35 | N/A |
Comparison Kalaris Therapeutics (KLRS) five years EPS CAGR with competitors
Kalaris Therapeutics (KLRS) five years EPS CAGR is -39.47%.